Grünenthal announces pricing of bond extension

EQS-News: Grünenthal GmbH / Key word(s): Bond/Issue of Debt Grünenthal announces pricing of bond extension 14.11.2025 / 15:30 CET/CEST The issuer is solely responsible for the content of this announcement. Grünenthal announces pricing of bond extension

Aachen, Germany, 14 November 2025 – Grünenthal, a science-based pharmaceutical company and a leader in pain management, today announced the extension of its existing issue of Senior Secured Notes due 2031 (the “Existing Notes”) by €175 million (the “Additional Notes”) to a total sum of €675 million. The Additional Notes are expected to be issued and settled on 26 November 2025 (the “Issue Date”).

The extension was made with the same interest rate of 4.625%, and maturity in 2031, as the Existing Notes. The Issuer’s outstanding Senior Secured Notes due 2028 and Senior Secured Notes due 2030 remain unchanged.

The Additional Notes were offered outside the United States in reliance on Regulation S (“Regulation S”) under the Securities Act of 1933, as amended (the “Securities Act”). The Additional Notes will be issued with a temporary international securities identification number (“ISIN”) (Temporary ISIN: XS3227188375) that will differ from the ISIN of the Existing Notes during the 40-day period prescribed by Regulation S, commencing on the Issue Date (the “Distribution Compliance Period”). Following the Distribution Compliance Period, the Additional Notes will become fully fungible with, and have the same ISIN as, the Existing Notes issued pursuant to Regulation S (Permanent ISIN: XS2951378434).

The net proceeds of the extension will be used to pay down existing bank liabilities and for general corporate purposes, which may include the funding of add-on acquisitions, payments under existing joint venture arrangements or similar cash outflows. As a result of this transaction, our new debt maturity profile and enhanced capital structure provide Grünenthal with a solid basis to further pursue our growth strategy.

Grünenthal will be announcing its financial results for the nine months ended September 30, 2025 on Friday, November 28, 2025.  Furthermore, in connection with this pricing announcement, we are also pre-announcing summary Q3 results that are in line with expectations as follows: we expect to report Q3 revenues of €1,351m and Adjusted EBITDA of €404m.